Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 1

Interventions

Cyclophosphamide 910Carboplatin 787pembrolizumab 746Paclitaxel 743Cisplatin 709Bevacizumab 707Gemcitabine 619Docetaxel 580Rituximab 549Radiotherapy 541Dexamethasone 512Nivolumab 489Doxorubicin 445Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 327fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Has results × TLC 388 × Clear all
NCT00747474 2019-11-18

Phase I Study of Intravenous LipotecanĀ® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors

Taiwan Liposome Company

Phase 1 Completed
54 enrolled 30 charts
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚔